http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103425859-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7610cef0de1410bf21e1e54706e208a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-00
filingDate 2012-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f252f139e5c6c7a2c888fa50a1d27d58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_010106fe4ecd619068b6a030bfc0ec3a
publicationDate 2013-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103425859-A
titleOfInvention Screening method of TTR (transthyretin) small-molecule inhibitors
abstract The invention aims to establish an efficient, fast and reliable screening method of TTR (transthyretin) small-molecule inhibitors, overcomes the defects of the prior art and is applicable to design of medicines for amyloidosis caused by TTR fibrosis. A small-molecule database is screened and predicted by means of 3D-QSAR (3-dimensional quantitative structure activity relationship), molecular docking, pharmacophore models and the like; small molecules capable of serving as lead compounds are determined preliminarily; further cell screening is performed. The screening method is fast and efficient; a plurality of drug screening and design methods based on receptors and ligands are applied; accordingly, reliability of screening results is improved greatly. Cell levels are subjected to biological screening by lead compounds obtained by screening, so that screening speed is higher and development and search cycle of novel inhibitors is shortened.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108701171-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108875298-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108875298-A
priorityDate 2012-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397419
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27731
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO46654
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02767
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID61872015
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8HXW1
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID246932
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07309
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24856
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP42204
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280948
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO55245
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP50390
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ29616
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5NVS2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49141
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49143
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP12303
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID946820
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID22139
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49142
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP30623
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7276
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO46375
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA4QNN7
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458437694
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565407
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07489
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP31779
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25201348
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397787
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100125183
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5U7I5
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23994
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCB7ZS96
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9MYN8

Total number of triples: 51.